Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,259 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Constrained C2 adsorbate orientation enables CO-to-acetate electroreduction.
Jin J, Wicks J, Min Q, Li J, Hu Y, Ma J, Wang Y, Jiang Z, Xu Y, Lu R, Si G, Papangelakis P, Shakouri M, Xiao Q, Ou P, Wang X, Chen Z, Zhang W, Yu K, Song J, Jiang X, Qiu P, Lou Y, Wu D, Mao Y, Ozden A, Wang C, Xia BY, Hu X, Dravid VP, Yiu YM, Sham TK, Wang Z, Sinton D, Mai L, Sargent EH, Pang Y. Jin J, et al. Nature. 2023 May;617(7962):724-729. doi: 10.1038/s41586-023-05918-8. Epub 2023 May 3. Nature. 2023. PMID: 37138081
Author Correction: TNF inhibitors target a mevalonate metabolite/TRPM2/calcium signaling axis in neutrophils to dampen vasculitis in Behçet's disease.
Zhang M, Kang N, Yu X, Zhang X, Duan Q, Ma X, Zhao Q, Wang Z, Wang X, Liu Y, Zhang Y, Zhu C, Gao R, Min X, Li C, Jin J, Cao Q, Liu R, Bai X, Yang H, Zhao L, Liu J, Chen H, Zhang Y, Liu W, Zheng W. Zhang M, et al. Among authors: jin j. Nat Commun. 2025 Jan 3;16(1):366. doi: 10.1038/s41467-024-55702-z. Nat Commun. 2025. PMID: 39753557 No abstract available.
Phase 2 study of serplulimab with the bevacizumab biosimilar HLX04 in the first-line treatment of advanced hepatocellular carcinoma.
Ren Z, Shao G, Shen J, Zhang L, Zhu X, Fang W, Sun G, Bai Y, Wu J, Liu L, Yuan Y, Zhang J, Li Z, Zhang L, Yin T, Wu J, Hou X, Yu H, Li J, Wang Q, Zhu J, Fan J; Serplulimab-HCC Investigators. Ren Z, et al. Cancer Immunol Immunother. 2025 Jan 3;74(2):69. doi: 10.1007/s00262-024-03917-w. Cancer Immunol Immunother. 2025. PMID: 39751879 Clinical Trial.
13,259 results
You have reached the last available page of results. Please see the User Guide for more information.